Cargando…

WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Arenas, Ernest, Saltó, Carmen, Villaescusa, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Lecture Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797852/ https://www.ncbi.nlm.nih.gov/pubmed/27386211 http://dx.doi.org/10.1186/2193-1801-4-S1-L49

Ejemplares similares

En1 and Wnt signaling in midbrain dopaminergic neuronal development
por: Alves dos Santos, Maria TM, et al.
Publicado: (2011)

Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells
por: Ásgrímsdóttir, Emilía Sif, et al.
Publicado: (2020)

WNT signaling mechanisms in nociception and sensitization of afferent neurons
por: Simonetti, Manuela
Publicado: (2015)

Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance
por: Blakely, Brette D., et al.
Publicado: (2011)

A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons
por: Nishimura, Kaneyasu, et al.
Publicado: (2023)

Computational model of midbrain dopaminergic neuron activity in ageing and obesity
por: Popovych, Svitlana, et al.
Publicado: (2013)

An interlocked oscillator model for high-frequency firing of the midbrain dopaminergic neuron
por: Kuznetsov, Alexey, et al.
Publicado: (2011)

WNT signaling in microglia and the glioma microenvironment
por: Schulte, Gunnar
Publicado: (2015)

Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020)

Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson’s disease
por: DAI, TING-LI, et al.
Publicado: (2014)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

Wnt5a Regulates Ventral Midbrain Morphogenesis and the Development of A9–A10 Dopaminergic Cells In Vivo
por: Andersson, Emma R., et al.
Publicado: (2008)

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
por: La Manno, Gioele, et al.
Publicado: (2016)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

The role of microvascular endothelial WNT signaling the formation of the blood brain barrier
por: Lampugnani, Maria Grazia, et al.
Publicado: (2015)

Dkk1 Regulates Ventral Midbrain Dopaminergic Differentiation and Morphogenesis
por: Ribeiro, Diogo, et al.
Publicado: (2011)

Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
por: Vahedi, Shahrooz, et al.
Publicado: (2010)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
por: Virdi, Gurvir S., et al.
Publicado: (2022)

A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration
por: Yang, Shanzheng, et al.
Publicado: (2018)

Functional neurosurgery in Parkinson's disease therapy
por: Lavano, A
Publicado: (2010)

Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
por: Wang, Mengmeng, et al.
Publicado: (2020)

Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson’s disease model
por: Xu, Peibo, et al.
Publicado: (2022)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation
por: Gyllborg, Daniel, et al.
Publicado: (2018)

Direct Glutamatergic Signaling From Midbrain Dopaminergic Neurons Onto Pyramidal Prefrontal Cortex Neurons
por: Pérez-López, José Luis, et al.
Publicado: (2018)

The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons
por: Alsanie, Walaa F., et al.
Publicado: (2022)

Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons
por: Alsanie, Walaa F., et al.
Publicado: (2022)

The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain
por: Alsanie, Walaa F., et al.
Publicado: (2023)

Dose-Dependent and Subset-Specific Regulation of Midbrain Dopaminergic Neuron Differentiation by LEF1-Mediated WNT1/b-Catenin Signaling
por: Nouri, Parivash, et al.
Publicado: (2020)

Interaction of NMDA Receptor and Pacemaking Mechanisms in the Midbrain Dopaminergic Neuron
por: Ha, Joon, et al.
Publicado: (2013)

Cortical regulation of dopaminergic neurons: role of the midbrain superior colliculus
por: Bertram, C., et al.
Publicado: (2013)

Transcriptional comparison of human induced and primary midbrain dopaminergic neurons
por: Xia, Ninuo, et al.
Publicado: (2016)

Efficient generation of dopaminergic induced neuronal cells with midbrain characteristics
por: Ng, Yi Han, et al.
Publicado: (2021)

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Genetics of Parkinsonism
por: Annesi, G
Publicado: (2010)

Sporadic Parkinsonism
por: Nicoletti, G
Publicado: (2010)

Immature Midbrain Dopaminergic Neurons Derived from Floor‐Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease
por: Qiu, Lifeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m9o4gocf63qpjac3i2p8qtlahe